Invention Grant
- Patent Title: Methods of using anti-CGRP antagonist antibodies
-
Application No.: US14719015Application Date: 2015-05-21
-
Publication No.: US09328168B2Publication Date: 2016-05-03
- Inventor: Joerg Zeller , Kristian T. Poulsen , Yasmina Noubia Abdiche , Jaume Pons , Sierra Jones Collier , Arnon Rosenthal
- Applicant: Labrys Biologics, Inc.
- Applicant Address: US CA Redwood City
- Assignee: LABRYS BIOLOGICS, INC.
- Current Assignee: LABRYS BIOLOGICS, INC.
- Current Assignee Address: US CA Redwood City
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C12P21/08 ; C07K16/00 ; C07K16/26 ; C07K16/18 ; A61K31/4045 ; A61K39/00
Abstract:
The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms, including headaches (e.g., migraine, cluster headache, and tension headache) and hot flushes, by administering an anti-CGRP antagonist antibody. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.
Public/Granted literature
- US20150291690A1 ANTAGONIST ANTIBODIES DIRECTED AGAINST CALCITONIN GENE-RELATED PEPTIDE AND METHODS USING SAME Public/Granted day:2015-10-15
Information query
